|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1995)) |
IUPAC Name ![]() |
| 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5718 | glimepiride |
Synonyms ![]() |
| Amaryl® |
| glimepride |
| HOE-490 |
| Sugral® |
Database Links ![]() |
|
| CAS Registry No. | 93479-97-1 |
| ChEMBL Ligand | CHEMBL1481 |
| DrugBank Ligand | DB00222 |
| PubChem CID | 3476 |
| Search Google for chemical match using the InChIKey | WIGIZIANZCJQQY-RUCARUNLSA-N |
| Search Google for chemicals with the same backbone | WIGIZIANZCJQQY |
| Search PubMed clinical trials | glimepiride |
| Search PubMed titles | glimepiride |
| Search PubMed titles/abstracts | glimepiride |
| Wikipedia | Glimepiride |
| Comments |
| Only approved by the EMA (2007) to be used in combination with pioglitazone (Tandemact®). Note that the PubChem CID listed above refers to the non-isomeric molecule. We show the isomeric form which corresponds to the structure held with the INN record for this compound. |